Q2 2026 Nath Bio-Genes (I) Ltd Earnings Call Transcript
Key Points
- Nath Bio-Genes (India) Ltd (BOM:537291) reported a 15.9% year-over-year revenue growth in H1 FY26, reaching INR3,199 million.
- The company's gross profit increased by 21.3% year-over-year, supported by a richer product mix and improved margins.
- The cotton business, a key revenue driver, recorded a steady growth of around 6% in volume and 26.3% in value year-over-year.
- The vegetable seeds segment emerged as the fastest-growing business, delivering almost 25% year-over-year value growth.
- The international joint venture in Uzbekistan is progressing well, with encouraging results in marketing activities and cotton production.
- The spread of illegal Bt cotton and illegal RRF cotton continues to undermine the organized sector, impacting the company's cotton business.
- Bajra saw a moderate decline due to lower acreages and softer rural sentiment.
- The company's working capital increased significantly due to higher receivables and inventory levels.
- EBITDA margin compression was noted due to enhanced marketing schemes, despite maintaining gross margins.
- The industry faces challenges from erratic monsoons and climate unpredictability, affecting crop yields and farmer sentiment.
Ladies and gentlemen, good day, and welcome to Nath Bio-Genes Limited Q2 and H1 FY26 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Ms. Deepika Sharma from Go India Advisors LLP. Thank you, and over to you, ma'am.
Thank you, Amshadh. Good afternoon, everyone, and welcome to the Q2 and H1 FY26 earnings call of Nath-Bio-Genes Limited. We have on the call Mr. Satish Kagliwal, Managing Director; Dr. Devinder Khurana, Executive Vice President; Mr. Amol Gupta, Chief Financial Officer; Mr. Harish Pandey, Sales; Dr. Venkatesh Kulkarni Research Lead.
We must remind you that the discussion on today's call may include certain forward-looking statements and must be therefore viewed in conjunction with the risks that the company faces. May I now request the management to take us through the financials and the business outlook, subsequent to which we will open the floor for Q&A.
Thank you, and over to you,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
